Mag-Bind® FFPE DNA/RNA 96 Kit
Omega Bio-TekSequentially isolate DNA and RNA in two separate eluates from the same FFPE sample. Xylene-free protocol
Sequentially isolate DNA and RNA in two separate eluates from the same FFPE sample. Xylene-free protocol
Cell-based assay expert shares how to overcome your cell-based challenges and drive the development of cutting-edge biotherapeutics
Jeanette Langner, PiCA, discusses the challenges of detecting polar pesticides in food products and new LC column technology streamlining analysis
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar
A Presidential award-winning laboratory has developed a new technology to address one of the most pressing challenges in nanomedicine
Drying chambers to lend a helping hand
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on AI image analysis, CRISPR reagents, cell morphology, cancer research, and more
HyClone Fetal Bovine Serum - Thermo HyClone Fetal Bovine Serum, U.S. Origin is filtered through serial 40µm (0.04µm) pore-size rated filters. Eliminate concerns about viral contamination in Fetal Bovine Serum (FBS) without compromising cell culture performance. HyClone FBS is widely used by those culturists who require an extensive biochemical profile. Defined FBS is filtered through the most retentive filters used in commerci…
A team of experts at Merck KGaA, Darmstadt, Germany, discuss their sustainable, animal-free, recombinant IgG antibodies, and reveal why these could soon become a laboratory must-have for most researchers
Plant biotechnology post grad, Sarannia Thanganathan, discusses her passion for research and how to overcome the challenges faced as a scientist
Discover how Biorbyt used ethical techniques to produce a new line of research tools to meet the challenges of the pandemic
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy